[{"address1": "2015 Peel Street", "address2": "11th Floor", "city": "Montreal", "state": "QC", "zip": "H3A 1T8", "country": "Canada", "phone": "514 336 7800", "fax": "514 331 9691", "website": "https://www.theratech.com", "industry": "Biotechnology", "sector": "Healthcare", "longBusinessSummary": "Theratechnologies Inc., a biopharmaceutical company, focuses on the development and commercialization of various therapies to address the unmet medical needs in the United States, Canada, and Europe. The company offers EGRIFTA SV for the reduction of excess abdominal fat in human immunodeficiency virus (HIV)-infected patients with lipodystrophy; and Trogarzo for the treatment of HIV-1 infection in heavily treatment-experienced adults with multidrug-resistant HIV-1 infection failing their current antiretroviral regimen. Its pipeline products include F8 Formulation that is in Phase 2b/3 clinical trials for studying tesamorelin for the treatment of nonalcoholic steatohepatitis; multi -dose pen injector for the administration of tesamorelin; SORT1+ Technology Platform for the development of proprietary peptides for cancer drug development targeting SORT1 receptors; Sudocetaxel Zendusortide, which is in Phase 1 Clinical Trial for various solid tumor types, including HR+ breast, triple negative breast, ovarian, endometrial, melanoma, thyroid, small cell lung, and prostate cancers. The company was incorporated in 1993 and is headquartered in Montreal, Canada.", "fullTimeEmployees": 103, "companyOfficers": [{"maxAge": 1, "name": "Mr. Paul  L\u00e9vesque", "age": 59, "title": "President, CEO & Director", "yearBorn": 1964, "fiscalYear": 2023, "totalPay": 1181649, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Philippe  Dubuc M.B.A., MBA", "age": 56, "title": "Senior VP & CFO", "yearBorn": 1967, "fiscalYear": 2023, "totalPay": 432313, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Jocelyn  Lafond L.L.M., LL.B.", "age": 55, "title": "General Counsel & Corporate Secretary", "yearBorn": 1968, "fiscalYear": 2023, "totalPay": 316294, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Christian  Marsolais Ph.D.", "age": 60, "title": "Senior VP & Chief Medical Officer", "yearBorn": 1963, "fiscalYear": 2023, "totalPay": 434605, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. John  Leasure", "age": 58, "title": "Global Commercial Officer", "yearBorn": 1965, "fiscalYear": 2023, "totalPay": 420909, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Hon. Andre  Dupras M.Sc.", "age": 59, "title": "Vice President of Human Resources", "yearBorn": 1964, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 10, "boardRisk": 2, "compensationRisk": 8, "shareHolderRightsRisk": 8, "overallRisk": 6, "governanceEpochDate": 1725148800, "compensationAsOfEpochDate": 1703980800, "maxAge": 86400, "priceHint": 4, "previousClose": 1.22, "open": 1.23, "dayLow": 1.22, "dayHigh": 1.24, "regularMarketPreviousClose": 1.22, "regularMarketOpen": 1.23, "regularMarketDayLow": 1.22, "regularMarketDayHigh": 1.24, "beta": 1.74, "forwardPE": 8.821428, "volume": 29627, "regularMarketVolume": 29627, "averageVolume": 37856, "averageVolume10days": 17470, "averageDailyVolume10Day": 17470, "bid": 0.8856, "ask": 1.57, "bidSize": 200, "askSize": 200, "marketCap": 57645600, "fiftyTwoWeekLow": 0.88, "fiftyTwoWeekHigh": 3.29, "priceToSalesTrailing12Months": 0.6981337, "fiftyDayAverage": 1.3984, "twoHundredDayAverage": 1.46255, "currency": "USD", "enterpriseValue": 78468024, "profitMargins": -0.084709994, "floatShares": 34243159, "sharesOutstanding": 45980000, "sharesShort": 7561, "sharesShortPriorMonth": 18256, "sharesShortPreviousMonthDate": 1721001600, "dateShortInterest": 1723680000, "sharesPercentSharesOut": 0.0002, "heldPercentInsiders": 0.06289, "heldPercentInstitutions": 0.51206, "shortRatio": 0.19, "shortPercentOfFloat": 0.0002, "bookValue": -0.505, "lastFiscalYearEnd": 1701302400, "nextFiscalYearEnd": 1732924800, "mostRecentQuarter": 1717113600, "netIncomeToCommon": -6995000, "trailingEps": -0.13, "forwardEps": 0.14, "enterpriseToRevenue": 0.95, "enterpriseToEbitda": 9.104, "exchange": "NCM", "quoteType": "EQUITY", "symbol": "THTX", "underlyingSymbol": "THTX", "shortName": "Theratechnologies Inc.", "longName": "Theratechnologies Inc.", "firstTradeDateEpochUtc": 1234535400, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EDT", "uuid": "884fbfec-7a61-3b13-b77d-a67bfc89456f", "gmtOffSetMilliseconds": -14400000, "currentPrice": 1.235, "targetHighPrice": 18.0, "targetLowPrice": 3.0, "targetMeanPrice": 10.5, "targetMedianPrice": 10.5, "recommendationMean": 2.0, "recommendationKey": "buy", "numberOfAnalystOpinions": 2, "totalCash": 36028000, "totalCashPerShare": 0.784, "ebitda": 8619000, "totalDebt": 59320000, "quickRatio": 0.954, "currentRatio": 1.103, "totalRevenue": 82571000, "revenuePerShare": 2.122, "returnOnAssets": 0.05154, "freeCashflow": -5819625, "operatingCashflow": -775000, "revenueGrowth": 0.255, "grossMargins": 0.75943, "ebitdaMargins": 0.10438, "operatingMargins": 0.14934, "financialCurrency": "USD", "trailingPegRatio": null, "__fetch_time": "2024-09-05"}]